National Institutes of Health Dermatology Funding Trends 2015–2019

    Kyla N. Price, Erin K. Collier, Swetha Atluri, Jennifer L. Hsiao, Vivian Y. Shi
    TLDR NIH dermatology funding increased by 14.7% from 2015 to 2019, but men and certain states and institutions received most of the money.
    From 2015 to 2019, the NIH awarded $554.2 million to 1,764 dermatology-related projects across 171 institutions, with a 14.7% funding increase over the period. Male recipients received 60.9% of the total funding, with an average annual difference of $24.3 million more than female recipients. PhD holders received the largest portion of funding (47.5%), followed by MDs (28.0%) and MD/PhDs (24.1%). The top five states and institutions received a significant portion of the funding, highlighting a concentration of resources. Despite increased funding for both genders, a notable gender gap persisted, emphasizing the need for continued support for female investigators. The study suggested that promoting funding distribution to less frequently awarded institutions could enhance diversity and support emerging researchers. The study analyzed NIH funding trends for dermatology from 2015 to 2019, revealing no downtrend in funding and a slight increase in female investigators (113 in 2019 vs. 111 in 2015). Unlike previous studies, it showed a leveling off in the fraction of MD recipients. The study highlighted the importance of diversifying grant awards across more institutions to enhance topic and expertise breadth. It also emphasized the need for mentorship programs and research fellowships to support underrepresented groups. The analysis included projects related to dermatologic topics and diseases with cutaneous manifestations, adjusting all funding to 2015 equivalent dollars. The study acknowledged limitations due to the lack of applicant demographic data and stated no conflicts of interest.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 253 results

      community Being Safe on Oral Minoxidil: tl;dr on the literature.

      in Research/Science  51 upvotes 10 months ago
      Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

      community Homemade topical spironolactone

      in Research/Science  25 upvotes 3 years ago
      The potential effectiveness of homemade topical spironolactone in treating hair loss, with studies suggesting it is more effective than finasteride and even minoxidil when used as monotherapy. The conversation also mentions that other anti-androgens are being developed which may soon hit the market.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 5 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community A Different Take on Curing MBP

       17 upvotes 6 years ago
      Addressing hair loss by focusing on posture, blood flow, and craniofacial development. Methods include improving posture, cardiovascular activity, scalp massages, healthy diet, meditation, using minoxidil, and addressing craniofacial issues.

      community 25M in Spain Considering Finasteride: Private Dermatology Experiences Needed

      in General  135 upvotes 3 weeks ago
      A 25-year-old from Spain is considering starting finasteride for hair loss after using minoxidil for two years with limited success. They seek advice on private dermatology practices in Spain, including prescription processes, treatment duration, and costs, and ask for experiences from others using finasteride.

    Similar Research

    6 / 1000+ results